SCHEMBL26248560

SCHEMBL26248560

CC(C)c1ccc(N2CCOCC2)nc1F

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 3/20 0.42
▸ SHMT2 P34897 3/20 0.42
▸ PIM1 P11309 1/20 0.42
▸ KMT2A Q03164 3/20 0.40
▸ HTT P42858 3/20 0.39
▸ ALDH1A1 P00352 3/20 0.39
▸ SMN1; SMN2 Q16637 3/20 0.39
▸ KDM4E B2RXH2 3/20 0.39
▸ MEN1 O00255 2/20 0.39
▸ HPGD P15428 2/20 0.39
▸ LMNA P02545 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ RECQL P46063 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ BCL2 P10415 1/20 0.39
▸ MCL1 Q07820 1/20 0.39
▸ BCL2A1 Q16548 1/20 0.39
▸ CRHBP P24387 1/20 0.39
▸ CRHR2 Q13324 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24195087 0.79 ALDH1A1 (0.48) GAAPIM1KMT2AHTTALDH1A1
SCHEMBL26247014 0.78 SOS1 (0.34) CNR2
SCHEMBL29955318 0.76 GAA (0.47) GAASHMT2PIM1KMT2AHTT
SCHEMBL31195879 0.76 GAA (0.45) GAAPIM1KMT2AHTTALDH1A1
SCHEMBL16908180 0.76 SMPD3 (0.50) GAAPIM1KMT2AHTTALDH1A1
SCHEMBL2369964 0.76 CNR2 (0.50) GAAPIM1KMT2AHTTALDH1A1
SCHEMBL25333250 0.76 GAA (0.45) GAAPIM1KMT2AHTTALDH1A1
SCHEMBL23565839 0.75 TSHR (0.41) GAASHMT2KMT2AALDH1A1KDM4E
SCHEMBL11991745 0.72 CNR2 (0.47) GAAKDM4ECNR2
SCHEMBL4547898 0.71 GAA (0.48) GAAKMT2AHTTALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230270751-A1 BENZODIAZEPINE DERIVATIVES USEFUL IN TREATING A RESPIRATORY SYNCYTIAL VIRUS INFECTION PFIZER INC. 2023-08-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230270751-A1 BENZODIAZEPINE DERIVATIVES USEFUL IN TREATING A RESPIRATORY SYNCYTIAL VIRUS INFECTION CNR1, CNR2, SIGMAR1 GAA 4692/4885SHMT2 2048/4885PIM1 2045/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback